Prurigo nodularis: An update on etiopathogenesis and therapy

Journal of Dermatological Treatment

Volumn 24, Issue 6, 2013, Pages 458-462

  Fostini, Anna Chiara ^a   Girolomoni, Giampiero ^a   Tessari, Gianpaolo ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

Nodular prurigo; Pathogenesis; Prurigo nodularis; RCT; Therapy

Indexed keywords

APREPITANT; BETAMETHASONE VALERATE; CALCIPOTRIOL; GABAPENTIN; NALTREXONE; PIMECROLIMUS; PREGABALIN; PSORALEN; TACROLIMUS; THALIDOMIDE;

ALPHA 1 ANTITRYPSIN DEFICIENCY; ALUMINUM OVERLOAD; AMENORRHEA; ANEMIA; ATYPICAL MYCOBACTERIOSIS; B CELL LYMPHOMA; BLADDER CARCINOMA; BRADYCARDIA; CELIAC DISEASE; COMORBIDITY; CONSTIPATION; CONTACT ALLERGY; DIABETES MELLITUS; DISEASE ASSOCIATION; DIZZINESS; DRUG ERUPTION; DRUG SAFETY; EDEMA; HEADACHE; HELICOBACTER INFECTION; HEPATITIS B; HEPATITIS C; HODGKIN DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOTENSION; INCREASED APPETITE; INSECT BITE; LEIOMYOMATOSIS; LIVER DYSFUNCTION; MALE SEXUAL DYSFUNCTION; MENTAL DISEASE; MOOD CHANGE; MYXEDEMA; NAUSEA; NEURODERMATITIS; NEUTROPENIA; NONHODGKIN LYMPHOMA; NUMMULAR DERMATITIS; OVARY INSUFFICIENCY; PHOTOTHERAPY; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; PRURITUS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SIDE EFFECT; SKIN NERVE; STOMACH CANCER; STRONGYLOIDIASIS; SYSTEMATIC REVIEW; TACHYCARDIA; THROMBOSIS; UREMIA; VENOUS STASIS; WEIGHT GAIN; XEROSIS;

AMINES; CHRONIC DISEASE; CYCLOHEXANECARBOXYLIC ACIDS; DERMATOLOGIC AGENTS; EPIDERMIS; FEMALE; GAMMA-AMINOBUTYRIC ACID; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; PHYSICAL THERAPY MODALITIES; PRURIGO; SEX FACTORS; SKIN;

EID: 84887899541     PISSN: 09546634     EISSN: 14711753     Source Type: Journal    
DOI: 10.3109/09546634.2013.814759     Document Type: Review

References (30)

1. Weisshaar E, Szepietowski JC, Darsow U, Misery L, Wallengren J, Mettang T, et al. European guideline on chronic pruritus. Acta Derm Venereol. 2012;92:563-581
2. Iking A, Grundmann S, Chatzigeorgakidis E, Phan NQ, Klein D, Ständer S. Prurigo as a symptom of atopic and non-atopic diseases: Aetiological survey in a consecutive cohort of 108 patients. J Eur Acad Dermatol Venereol. 2013;27:550-557
3. Ständer S, Stumpf A, Osada N, Wilp S, Chatzigeorgakidis E, Pfleiderer B. Gender differences in chronic pruritus: Women present different morbidity, more scratch lesions and higher burden. Br J Dermatol. 2013;168:1273-1280
4. Weigelt N, Metze D, Ständer S. Prurigo nodularis: Systematic analysis of 58 histological criteria in 136 patients. J Cutan Pathol. 2010;37: 578-586
5. Winhoven SM, Gawkrodger DJ. Nodular prurigo: Metabolic diseases are a common association. Clin Exp Dermatol. 2007;32:224-225
6. Pugliarello S, Cozzi A, Gisondi P, Girolomoni G. Phenotypes of atopic dermatitis. J Dtsch Dermatol Ges. 2011;9:12-20
7. Yosipovitch G, Samuel LS. Neuropathic and psychogenic itch. Dermatol Ther. 2008;21:32-41
8. Bharati A, Wilson NJE. Peripheral neuropathy associated with nodular prurigo. Clin Exp Dermatol. 2007;32:67-70
9. Liang Y, Jacobi HH, Reimert CM, Haak-Frendscho M, Marcusson JA, Johansson O. CGRP-immunoreactive nerves in prurigo nodularis-an exploration of neurogenic inflammation. J Cutan Pathol. 2000;27:359-366
10. Johansson O, Liang Y, Marcusson JA, Reimert CM. Eosinophil cationic protein-and eosinophil-derived neurotoxin/eosinophil protein X-immunoreactive eosinophils in prurigo nodularis. Arch Dermatol Res. 2000;292:371-378
11. Haas S, Capellino S, Phan NQ, Böhm M, Luger TA, Straub RH, et al. Low density of sympathetic nerve fibers relative to substance P-positive nerve fibers in lesional skin of chronic pruritus and prurigo nodularis. J Dermatol Sci. 2010;58:193-197
12. Emtestam L, Hagströmer L, Dou Y-C, Sartorius K, Johansson O. PGP 9.5 distribution patterns in biopsies from early lesions of atopic dermatitis. Arch Dermatol Res. 2012;304:781-785
13. Johansson O, Liang Y, Emtestam L. Increased nerve growth factor-and tyrosine kinase A-like immunoreactivities in prurigo nodularis skin - An exploration of the cause of neurohyperplasia. Arch Dermatol Res. 2002;293:614-619
14. Schuhknecht B, Marziniak M, Wissel A, Phan NQ, Pappai D, Dangelmaier J, et al. Reduced intraepidermal nerve fibre density in lesional and nonlesional prurigo nodularis skin as a potential sign of subclinical cutaneous neuropathy. Br J Dermatol. 2011;165:85-91
15. Ikoma A, Steinhoff M, Ständer S, Yosipovitch G, Schmelz M. The neurobiology of itch. Nat Rev Neurosci. 2006;7:535-547
16. Abadía Molina F, Burrows NP, Jones RR, Terenghi G, Polak JM. Increased sensory neuropeptides in nodular prurigo: A quantitative immunohistochemical analysis. Br J Dermatol. 1992; 127:344-351
17. Takada S, Kou K, Ikezawa Z, Aihara M. Aberrant epidermal expression of semaphorin 3A and nerve growth factor in prurigo nodularis. J Dermatol. 2013;40:1-2
18. Gencoglan G, Inanir I, Gunduz K. Therapeutic hotline: Treatment of prurigo nodularis and lichen simplex chronicus with gabapentin. Dermatol Ther. 2010;23:194-198
19. Mazza M, Guerriero G, Marano G, Janiri L, Bria P, Mazza S. Treatment of prurigo nodularis with pregabalin. J Clin Pharm Ther. 2013;38:16-18
20. Ständer S, Luger T, Metze D. Treatment of prurigo nodularis with topical capsaicin. J Am Acad Dermatol. 2001;44:471-478
21. Hoeijmakers JG, Faber CG, Lauria G, Merkies IS, Waxman SG. Small-fibre neuropathies-advances in diagnosis, pathophysiology and management. Nat Rev Neurol. 2012;8:369-379
22. Fukushi S, Yamasaki K, Aiba S. Nuclear localization of activated STAT6 and STAT3 in epidermis of prurigo nodularis. Br J Dermatol. 2011;165:990-996
23. Sestito R, Madonna S, Scarponi C, Cianfarani F, Failla CM, Cavani A, et al. STAT3-dependent effects of IL-22 in human keratinocytes are counterregulated by sirtuin 1 through a direct inhibition of STAT3 acetylation. FASEB J. 2011;25:916-927
24. Sonkoly E, Muller A, Lauerma AI, Pivarcsi A, Soto H, Kemeny L, et al. IL-31: A new link between T cells and pruritus in atopic skin inflammation. J Allergy Clin Immunol. 2006;117:411-417
25. Saraceno R, Chiricozzi A, Nisticò SP, Tiberti S, Chimenti S. An occlusive dressing containing betamethasone valerate 0.1% for the treatment of prurigo nodularis. J Dermatolog Treat. 2010;21:363-366
26. Wong SS, Goh CL. Double-blind, right/left comparison of calcipotriol ointment and betamethasone ointment in the treatment of Prurigo nodularis. Arch Dermatol. 2000;136:807-808
27. Ständer S, Schürmeyer-Horst F, Luger TA, Weisshaar E. Treatment of pruritic diseases with topical calcineurin inhibitors. Ther Clin Risk Manag. 2006;2:213-218
28. Razeghi E, Eskandari D, Ganji MR, Meysamie AP, Togha M, Khashayar P. Gabapentin and uremic pruritus in hemodialysis patients. Ren Fail. 2009;31:85-90
29. Ahuja RB, Gupta GK. A four arm, double blind, randomized and placebo controlled study of pregabalin in the management of post-burn pruritus. Burns. 2013;39:24-29
30. Chen M, Doherty SD, Hsu S. Innovative uses of thalidomide. Dermatol Clin. 2010;28:577-586